Previous 10 | Next 10 |
INOVIO to Report Fourth Quarter and Year-End 2023 Financial Results on March 6, 2024 PR Newswire PLYMOUTH MEETING, Pa. , Feb. 21, 2024 /PRNewswire/ -- INOVIO (NASDAQ:INO), a biotechnology company focused on developing and commercializing DNA medicines to hel...
2024-02-14 16:02:06 ET Inovio Pharmaceuticals, Inc. (INO) Oppenheimer 34th Annual Healthcare Life Sciences Conference February 14, 2024, 12:40 PM ET Company Participants Jacque Shea - President and CEO Conference Call Participants Hartaj Singh - Oppenheimer ...
INOVIO to Present at the Oppenheimer 34th Annual Healthcare Life Sciences Conference PR Newswire PLYMOUTH MEETING, Pa. , Feb. 7, 2024 /PRNewswire/ -- INOVIO (NASDAQ:INO), a biotechnology company focused on developing and commercializing DNA medicines to help trea...
2024-02-05 19:20:15 ET Summary INO-3107 has jumped to the forefront of Inovio's pipeline. Inovio plans a near term BLA fuling for INO-3107. It has liquidity that should take it to Q2, 2025. This is my eighth Inovio ( INO ) article following my most recent 06/2023...
Inseego Corp. (Nasdaq: INSG), a leader in 5G edge cloud solutions, today announced that the company will release its financial results for the fourth quarter and year ended December 31, 2023 after the financial markets close on February 21, 2024. The financial statements and earnings press re...
2024-01-25 13:45:35 ET More on Inovio Pharmaceuticals Inovio Pharmaceuticals, Inc. 2023 Q3 - Results - Earnings Call Presentation Inovio Pharmaceuticals, Inc. (INO) Q3 2023 Earnings Call Transcript Inovio Pharmaceuticals to effect 1-for-12 reverse stock split to rega...
2024-01-24 08:02:09 ET Inovio Pharmaceuticals Inc (INO) announced stock split at a ratio of 1-for-12 on 2024-01-25 ... Full story available on KlickAnalytics.com
2024-01-23 08:22:08 ET More on Inovio Pharmaceuticals Inovio Pharmaceuticals, Inc. 2023 Q3 - Results - Earnings Call Presentation Inovio Pharmaceuticals, Inc. (INO) Q3 2023 Earnings Call Transcript Inovio stock surges to seven-month high Inovio plans to submi...
INOVIO Announces Effective Date of 1-for-12 Reverse Stock Split PR Newswire PLYMOUTH MEETING, Pa. , Jan. 23, 2024 /PRNewswire/ -- INOVIO (NASDAQ:INO), a biotechnology company focused on developing and commercializing DNA medicines to help treat and prot...
Common Stock Will Begin Trading on a Split-Adjusted Basis on January 24, 2024 Inseego Corp. (Nasdaq: INSG) (the “Company”) today announced that it intends to effect a 1-for-10 reverse stock split of its issued and outstanding shares of common stock (the “Reverse Sto...
News, Short Squeeze, Breakout and More Instantly...
Inovio Pharmaceuticals Inc. Company Name:
INO Stock Symbol:
NASDAQ Market:
Inovio Pharmaceuticals Inc. Website:
2024-07-16 13:42:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
Inseego Corp. (Nasdaq: INSG), a technology leader in 5G mobile and fixed wireless solutions for mobile network operators, Fortune 500 enterprises and SMBs, today announced that the company will release its financial results for the second quarter of 2024, ended June 30, 2024, after the financial ...
INO-3107 Awarded the Innovation Passport Designation Under U.K. Government's Innovative Licensing and Access Pathway PR Newswire Award recognizes the potential for INO-3107 to be the first therapeutic option in the United Kingdom for patients suffering from Recurrent Respi...